Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 1/2014

01.02.2014 | short review

Untreated endometrial cancer: a case report and a review of the literature

verfasst von: Sofie Leisby Antonsen, MD, PhD, Jens Jørgen Kjer, MD, Lian Ulrich, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The natural course of untreated endometrial adenocarcinoma is difficult to describe because observation of an already diagnosed cancer is unethical. However, occasionally, patients refuse therapy for different reasons, thus providing the opportunity to observe the natural course of the malignant disease. These patients are for obvious reasons rare cases. We present such a case and a review of the literature.

Methods

This article is a description of one case story and a systematic review of the literature.

Results

A case of a premenopausal woman with a well-differentiated endometrial endometrioid adenocarcinoma is presented. She did not want any therapy. She was followed for 3 years with growing tumor burden and finally died. Five other cases of untreated endometrial carcinoma were found in the literature. The patients had varying length of survival (range: 5 months to 12 years), but all patients experienced generally good health several years after diagnosis.

Conclusion

The case presented here and the literature reviews indicate that patients with untreated endometrial endometrioid carcinoma may survive for several years. The exact lifetime increment gained by treatment in patients with favorable prognostic factors will remain unknown. However, it should never be used as a pretext for delaying or not treating these patients.
Literatur
1.
Zurück zum Zitat Armentano G, Bracco PL, Brizio R, Perelli G. Untreated endometrial adenocarcinoma: a case report. Eur J Gynaecol Oncol. 1997;18(2):144–5.PubMed Armentano G, Bracco PL, Brizio R, Perelli G. Untreated endometrial adenocarcinoma: a case report. Eur J Gynaecol Oncol. 1997;18(2):144–5.PubMed
2.
Zurück zum Zitat Norstrom A, Granberg S. Natural history of endometrial cancer: report of one woman who did not accept treatment. Acta Obstet Gynecol Scand. 2004 May;83(5):506–7.PubMedCrossRef Norstrom A, Granberg S. Natural history of endometrial cancer: report of one woman who did not accept treatment. Acta Obstet Gynecol Scand. 2004 May;83(5):506–7.PubMedCrossRef
3.
Zurück zum Zitat Levy T, Golan A, Menczer J. Endometrial endometrioid carcinoma: a glimpse at the natural course. Am J Obstet Gynecol. 2006 Aug;195(2):454–7.PubMedCrossRef Levy T, Golan A, Menczer J. Endometrial endometrioid carcinoma: a glimpse at the natural course. Am J Obstet Gynecol. 2006 Aug;195(2):454–7.PubMedCrossRef
4.
Zurück zum Zitat Pirog EC, Heller DS, Westhoff C. Endometrial adenocarcinoma—lack of correlation between treatment delay and tumor stage. Gynecol Oncol. 1997 Dec;67(3):303–8.PubMedCrossRef Pirog EC, Heller DS, Westhoff C. Endometrial adenocarcinoma—lack of correlation between treatment delay and tumor stage. Gynecol Oncol. 1997 Dec;67(3):303–8.PubMedCrossRef
5.
Zurück zum Zitat Liu JR, Conaway M, Rodriguez GC, Soper JT, Clarke-Pearson DL, Berchuck A. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol. 1995 Oct;86(4 Pt 1):486–90.PubMedCrossRef Liu JR, Conaway M, Rodriguez GC, Soper JT, Clarke-Pearson DL, Berchuck A. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol. 1995 Oct;86(4 Pt 1):486–90.PubMedCrossRef
6.
Zurück zum Zitat Menczer J, Krissi H, Chetrit A, Gaynor J, Lerner L, Ben-Baruch G, et al. The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):774–8.PubMedCrossRef Menczer J, Krissi H, Chetrit A, Gaynor J, Lerner L, Ben-Baruch G, et al. The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):774–8.PubMedCrossRef
7.
Zurück zum Zitat Crawford SC, Davis JA, Siddiqui NA, de Caestecker L, Gillis CR, Hole D, et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ. 2002 Jul 27;325(7357):196.PubMedCentralPubMedCrossRef Crawford SC, Davis JA, Siddiqui NA, de Caestecker L, Gillis CR, Hole D, et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ. 2002 Jul 27;325(7357):196.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Martin-Hirsch PPL, Jarvis GG, Kitchener HC, Lilford R. Progestagens for endometrial cancer. Cochrane Database Syst Rev. 1999, Issue 4. Art. No. CD001040. doi:10.1002/14651858.CD001040. Martin-Hirsch PPL, Jarvis GG, Kitchener HC, Lilford R. Progestagens for endometrial cancer. Cochrane Database Syst Rev. 1999, Issue 4. Art. No. CD001040. doi:10.1002/14651858.CD001040.
9.
Zurück zum Zitat Bouros D, Papadakis K, Siafakas N, Fuller AF, Jr. Natural history of patients with pulmonary metastases from uterine cancer. Cancer. 1996 Aug 1;78(3):441–7.PubMedCrossRef Bouros D, Papadakis K, Siafakas N, Fuller AF, Jr. Natural history of patients with pulmonary metastases from uterine cancer. Cancer. 1996 Aug 1;78(3):441–7.PubMedCrossRef
10.
Zurück zum Zitat van Wijk FH, van der Burg ME, Burger CW, Vergote I, van Doorn HC. Management of surgical stage III and IV endometrioid endometrial carcinoma: an overview. Int J Gynecol Cancer. 2009 Apr;19(3):431–46.PubMedCrossRef van Wijk FH, van der Burg ME, Burger CW, Vergote I, van Doorn HC. Management of surgical stage III and IV endometrioid endometrial carcinoma: an overview. Int J Gynecol Cancer. 2009 Apr;19(3):431–46.PubMedCrossRef
11.
Zurück zum Zitat Ulrich LS. Endometrial cancer, types, prognosis, femalehormones and antihormones. Climacteric. 2011 Aug;14(4):418–25.PubMedCrossRef Ulrich LS. Endometrial cancer, types, prognosis, femalehormones and antihormones. Climacteric. 2011 Aug;14(4):418–25.PubMedCrossRef
Metadaten
Titel
Untreated endometrial cancer: a case report and a review of the literature
verfasst von
Sofie Leisby Antonsen, MD, PhD
Jens Jørgen Kjer, MD
Lian Ulrich, MD
Publikationsdatum
01.02.2014
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2014
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-013-0125-5

Weitere Artikel der Ausgabe 1/2014

memo - Magazine of European Medical Oncology 1/2014 Zur Ausgabe